Veracyte VCYT Market capitalization

Market capitalization at other companies

Myriad GeneticsMYGN

$420.79M-48.0%

Biodesix, Inc.BDSX

$233.52M+479%

Castle BiosciencesCSTL

$729.9M+27.9%

Personalis, Inc.PSNL

$666.5M+115%

Guardant HealthGH

$12.12B+130%

Natera, Inc.NTRA

$38.88B+65.7%

FAQ

What is Veracyte's market capitalization?

Veracyte (VCYT) reported market capitalization of $2.56B in Q1 2026.

How has Veracyte's market capitalization changed year-over-year?

Veracyte's market capitalization increased by 10.7% year-over-year, from $2.31B to $2.56B.

What is the long-term trend for Veracyte's market capitalization?

Over 5 years (2020 to 2025), Veracyte's market capitalization has grown at a -0.9% compound annual growth rate (CAGR), from $3.48B to $3.33B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.